Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Pink

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2023
Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin-4/13 InhibitorCatherine D Hughes, Joseph Nathan, Libin Mathew, et al.
Dermatology and Therapy|February 4, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DAREJonathan I Silverberg, Eric L Simpson, Andrew E Pink, et al.
BJGP Open|November 4, 2020
General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approachDiamant Thaçi, Pablo de la Cueva, Andrew E Pink, et al.
European Journal of Dermatology : EJD|July 22, 2022
Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7Koji Masuda, Amy M Delozier, Jill Kolodsick, et al.
The Journal of Dermatological Treatment|February 25, 2020
Long-term topical management of psoriasis: the road aheadSiegfried Segaert, Piergiacomo Calzavara-Pinton, Pablo de la Cueva, et al.
The British Journal of Dermatology|January 30, 2023
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topicDavid Gleeson, Jonathan N W N Barker, Francesca Capon, et al.
Dermatology and Therapy|January 19, 2026
Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysisAndrew E Pink, John Houghton, Holly White, et al.
The Journal of Investigative Dermatology|July 2, 2025
Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemMariel L James, Andrew E Pink, Richard T Woolf, et al.
Journal of Cutaneous Medicine and Surgery|June 7, 2026
Can Systemic Immunomodulatory Therapy Induce Remission of Atopic Dermatitis? A Systematic ReviewDavid Gleeson, John Y W Lee, Noor Leelo, et al.
The Journal of Investigative Dermatology|May 25, 2012
Mutations in the γ-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)Andrew E Pink, Michael A Simpson, Nemesha Desai, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2023
Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin-4/13 InhibitorCatherine D Hughes, Joseph Nathan, Libin Mathew, et al.
Dermatology and Therapy|February 4, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DAREJonathan I Silverberg, Eric L Simpson, Andrew E Pink, et al.
BJGP Open|November 4, 2020
General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approachDiamant Thaçi, Pablo de la Cueva, Andrew E Pink, et al.
European Journal of Dermatology : EJD|July 22, 2022
Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7Koji Masuda, Amy M Delozier, Jill Kolodsick, et al.
The Journal of Dermatological Treatment|February 25, 2020
Long-term topical management of psoriasis: the road aheadSiegfried Segaert, Piergiacomo Calzavara-Pinton, Pablo de la Cueva, et al.
The British Journal of Dermatology|January 30, 2023
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topicDavid Gleeson, Jonathan N W N Barker, Francesca Capon, et al.
Dermatology and Therapy|January 19, 2026
Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysisAndrew E Pink, John Houghton, Holly White, et al.
The Journal of Investigative Dermatology|July 2, 2025
Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemMariel L James, Andrew E Pink, Richard T Woolf, et al.
Journal of Cutaneous Medicine and Surgery|June 7, 2026
Can Systemic Immunomodulatory Therapy Induce Remission of Atopic Dermatitis? A Systematic ReviewDavid Gleeson, John Y W Lee, Noor Leelo, et al.
The Journal of Investigative Dermatology|May 25, 2012
Mutations in the γ-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa)Andrew E Pink, Michael A Simpson, Nemesha Desai, et al.
Pageof 7